166 related articles for article (PubMed ID: 19366361)
21. [Problematic resistance of pneumococcal antibiotic resistance].
Marchal V; Melin P; Hayette MP; Christiaens G; De Mol P
Rev Med Liege; 2003 Nov; 58(11):675-80. PubMed ID: 14748195
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant Streptococcus pneumoniae.
Tayloe D
N Engl J Med; 2001 Apr; 344(17):1329-30; author reply 1330-1. PubMed ID: 11336020
[No Abstract] [Full Text] [Related]
23. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
Traut V
Dtsch Med Wochenschr; 2008 May; 133(22):1207-8; author reply 1208. PubMed ID: 18491279
[No Abstract] [Full Text] [Related]
24. Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia.
Kastrin T; Gubina M; Paragi M; Kolman J; Cizman M; Kraigher A; Ribic H; Sadowy E; Hryniewicz W
J Antimicrob Chemother; 2008 Sep; 62(3):628-9. PubMed ID: 18474511
[No Abstract] [Full Text] [Related]
25. Resurgence of the multiresistant pneumococcus in the United States: a commentary.
Klugman KP; McGee L
Pediatr Infect Dis J; 2007 Jun; 26(6):473-4. PubMed ID: 17529861
[No Abstract] [Full Text] [Related]
26. The antimicrobial resistance profile of Streptococcus pneumoniae.
Reinert RR
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():7-11. PubMed ID: 19366363
[TBL] [Abstract][Full Text] [Related]
27. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
Couch KA; Geide T
Am J Health Syst Pharm; 2014 Mar; 71(5):417-24. PubMed ID: 24534597
[TBL] [Abstract][Full Text] [Related]
28. Incorrect identification of Streptococcus pneumoniae and its effect on antimicrobial resistance rates.
Song JH; Baek JY; Cheong HS; Peck KR; Ko KS
Int J Antimicrob Agents; 2009 Jan; 33(1):93-5. PubMed ID: 18789853
[No Abstract] [Full Text] [Related]
29. Serotype replacement in perspective.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C22-4. PubMed ID: 19545935
[TBL] [Abstract][Full Text] [Related]
30. Multidrug-resistant Streptococcus pneumoniae.
Foster DA; Heller ST; Young JK
N Engl J Med; 2001 Apr; 344(17):1329; author reply 1330-1. PubMed ID: 11336021
[No Abstract] [Full Text] [Related]
31. New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008).
Imöhl M; Reinert RR; van der Linden M
Int J Antimicrob Agents; 2009 Sep; 34(3):271-3. PubMed ID: 19419844
[TBL] [Abstract][Full Text] [Related]
32. Increase in pneumococcus macrolide resistance, USA.
Hicks LA; Monnet DL; Roberts RM
Emerg Infect Dis; 2010 May; 16(5):896-7. PubMed ID: 20409403
[No Abstract] [Full Text] [Related]
33. Pneumococcus and sickle cell disease: the beginning of the end?
Steinberg MH
Clin Infect Dis; 2007 Jun; 44(11):1434-5. PubMed ID: 17479938
[No Abstract] [Full Text] [Related]
34. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
35. Antibiotic usage and the development of resistance.
Fernandes P; Oldach D
Clin Infect Dis; 2015 Apr; 60(7):1139-40. PubMed ID: 25542895
[No Abstract] [Full Text] [Related]
36. Raising the profile of pneumococcal disease.
Murdoch DR
Intern Med J; 2008 Jun; 38(6):381-3. PubMed ID: 18613895
[No Abstract] [Full Text] [Related]
37. Resistant Pneumococcus: a worldwide problem.
Schutze GE; Kaplan SL; Jacobs RF
Infection; 1994; 22(4):233-7. PubMed ID: 8002081
[No Abstract] [Full Text] [Related]
38. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
Yokota S; Ohkoshi Y; Fujii N
Diagn Microbiol Infect Dis; 2009 Sep; 65(1):76-80. PubMed ID: 19679241
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region.
Borg MA; Tiemersma E; Scicluna E; van de Sande-Bruinsma N; de Kraker M; Monen J; Grundmann H;
Clin Microbiol Infect; 2009 Mar; 15(3):232-7. PubMed ID: 19154490
[TBL] [Abstract][Full Text] [Related]
40. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
